- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01009411
Labor Progress Indices and the Dynamics of the Individual Contraction During the Active Stage of Labor
Physiological Study of the Active Stage of Labor
Objective of the study: to obtain new data on the dynamics of the labor process, cervix dilatation and head station on the labor process and to develop a new progress indices.
Background: the best method used today to supervise the labor process is to follow cervix dilatation and head station. Today, the physician or the midwife use manual examination to estimate cervix dilatation and head station. This examination is perform many times in a normal labor process, and even more if there is any delay. The information from these examinations is inaccurate and non-continuous. In case of delay in the labor process, the delay will diagnosed late, because the frequency of the manual examination is about once an hour.
With the assistance of the BirthTrack device we can get continuous data on the labor process and get indices to estimate the labor process progress without the use of vaginal (manual) examination.
40 women in an active labor will take part in the study.
Method: by connecting sensors to the woman abdomen, to the cervix and to the baby head we follow the cervix dilatation and the fetus head station.
Study Overview
Status
Conditions
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
-
Nahariya, Israel
- Westren Gallilie Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Nulliparous women 18 years or older admitted to the labor and delivery unit in active labor (3cm dilatation and contractions).
- Parturients with epidural anesthesia
- Singleton fetus in vertex presentation
- Gestational age 37 or more
- Reassuring fetal heart tracing
- The woman is able to read and understand the consent form
Exclusion Criteria:
- Parturients in natural birth without epidural anesthesia
- Low lying placenta
- Known or suspected fetal or maternal infection
- Maternal thrombocytopenia
- Maternal bleeding disorder
- Known major fetal malformation
- Suspected fetal growth restriction
- Subjects with significant psychiatric history
- Subjects with indication for immediate delivery
- Maternal History of HIV and/or blood transmitted hepatitis and/or active genital Herpes
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
---|
Control
Patients in active phase of labor not augmented
|
Augmented
Augmentation leading to normal progress
|
Caesarean section
Augmentation leading to Caesarean section
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Birth Track measurements versus manual measurements
Time Frame: 1 year
|
1 year
|
Collaborators and Investigators
Collaborators
Investigators
- Study Chair: Prof. Ofer Barnea, Phd., Barnev Ltd
- Study Director: Prof. Ofer Barnea, Phd., Barnev Ltd
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- BT-1-IS-001
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Labor
-
University Hospital, GenevaQIAGEN Gaithersburg, Inc; Hologic, Inc.; Pregnolia ACCompletedLabor Onset | Labor, Induced | Labor, Obstetric | Predictive ModelSwitzerland
-
MemorialCare Health SystemCompletedLength of Labor | Second Stage of Labor | Intravenous Hydration of LaborUnited States
-
Raed SalimCompleted
-
University of RochesterJuniper Pharmaceuticals, Inc.WithdrawnLabor, PrematureUnited States
-
CAMC Health SystemCompleted
-
HaEmek Medical Center, IsraelCompleted
-
Hospital Clinic of BarcelonaCompletedThreatened Premature LaborSpain
-
Oslo University HospitalCompletedLabor (Obstetrics)--Complications | Labor; Prolonged, First StageNorway
-
University of TennesseeRecruitingLabor Onset and Length Abnormalities | Labor Long | Prolonged Labor | Labor; PoorUnited States
-
Hospital Miguel ServetCompletedPregnancy | Obstetric Labor | Cervical Ripening | Induced Labor